Intellia Therapeutics, Inc.
NASDAQ:NTLABiotechnology
Healthcare
$9.52 +0.14%
+$0.02 today
- Market cap
- $1.34B
- Beta
- 1.81
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$3.33
52W Low $7.95High $28.25
Volume 9.96M
Average 6.11M
Price history
Intellia Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+18.41%
Period high
$17.84
Period low
$8.04
Latest
$9.52
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K/A | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 3, 2026 | Nov 3, 2026 | |
| 4 | Oct 28, 2026 | Oct 28, 2026 | |
| 3 | Oct 28, 2026 | Oct 28, 2026 | |
| 4 | Oct 6, 2026 | Oct 6, 2026 | |
| 8-K | Sep 8, 2026 | Sep 8, 2026 | |
| 8-K | Sep 4, 2026 | Sep 4, 2026 | |
| 4 | Aug 24, 2026 | Aug 24, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 |
Competitors
Who does Intellia Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about NTLA's filings, answered from its disclosures.
What is the latest NTLA filing?
The latest filing shown is 8-K/A dated Nov 13, 2026.
How many recent filings does NTLA have?
Intrinsic Alpha currently shows 20 recent filings for NTLA.
Continue the stock analysis
Jump to another research area for this company.